Postprocessing method to segregate and quantify the broad components underlying the phosphodiester spectral region of in vivo 31P brain spectra

Magnetic Resonance in Medicine

Volumn 45, Issue 3, 2001, Pages 390-396

  Stanley, Jeff A ^a,b   Pettegrew, Jay W ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

In vivo; Phosphodiester; Phospholipid; Quantification

Indexed keywords

METABOLITES; MOLECULES; PHOSPHOLIPIDS;

CATABOLIC PRODUCTS; HEALTHY INDIVIDUALS; IN-VIVO; MEMBRANE PHOSPHOLIPIDS; PHOSPHODIESTERS; POSTPROCESSING METHODS; QUANTIFICATION; SPECTRAL INFORMATION;

ESTERS;

ESTER DERIVATIVE; MEMBRANE PHOSPHOLIPID; PHOSPHORUS DERIVATIVE;

ACCURACY; ADULT; ARTICLE; BRAIN; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGING SYSTEM; MALE; METABOLITE; NORMAL HUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; SPECTRUM;

EID: 0035108680     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2594(200103)45:3<390::AID-MRM1051>3.0.CO;2-D     Document Type: Article

References (43)

1. Mapping of metabolites in whole animals by 31P NMR using surface coils
2. Variations in the in vivo P-31 MR spectra of the developing human brain during postnatal life, Work in progress
3. 31P magnetic resonance spectroscopy study in vivo
4. Study of the maturation of the child's brain using 31P-MRS
5. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in vivo human brain
6. Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study
7. Magnetic resonance spectroscopic changes in Alzheimer's disease
8. In vivo MR spectroscopy of human dementia
9. Alterations in brain high-energy phosphate and membrane phospholipid metabolism, in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy
10. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy
11. Magnetic resonance spectroscopy in affective disorders
12. Magnetic resonance spectroscopy in schizophrenia. Methodological issues and findings - Part II
13. Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat
14. 31P magnetic resonance spectroscopy studies of developing brain
15. 31P nuclear magnetic resonance and the head group structure of phospholipids in membranes
16. 31P-NMR lineshapes
17. Phosphorus-31 nuclear magnetic resonance spectra characteristic of hexagonal and isotropic phospholipid phases generated from phosphatidylethanolamine in the bilayer phase
18. Enzymatic pathways of phospholipid metabolism in the nervous system
19. Chemical characterization of a prominent phosphomonoester resonance from mammalian brain. 31P and 1H NMR analysis at 4.7 and 14.1 Tesla
20. Phospholipid composition and metabolism in the developing and aging nervous system
21. Localized 31P NMR spectroscopy of the adult human brain in vivo using stimulated-echo (STEAM) sequences
22. Short TE phosphorus spectroscopy using a spin-echo pulse
23. Quantifying 1H decoupled in vivo 31P brain spectra
24. Comparison of sup 31P NMR spectra of in vivo rat brain using convolution difference and saturation with a surface coil. Source of the broad component in the brain spectrum
25. 31P NMR detection of mobile dog brain phospholipids
26. Phospholipid bilayer contribution to 31P NMR spectra in vivo
27. Characterization of the broad resonance in 31P NMR spectra of excised rat brain
28. Spin-spin relaxation of the phosphodiester resonance in the 31P NMR spectrum of human brain. The determination of the concentrations of phosphodiester components
29. 31P-NMR study of brain phospholipid structures in vivo
30. Investigation of broad resonances in 31P NMR spectra of the human brain in vivo
31. A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls
32. Selective suppression of the cranial bone resonance from sup 31P NMR experiments with rat brain in vivo
33. An algorithm for least-squares estimation of non-linear parameters
34. P-31 nuclear magnetic resonance analysis of brain: The perchloric acid extract spectrum
35. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations
36. Membrane interactions of a phosphomonoester elevated early in Alzbeimer's disease
37. Endoplasmic reticulum: The major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengths
38. 31P NMR studies of excised gray and white calf brain
39. Human primary brain tumour metabolism in vivo: A phosphorus magnetic resonance spectroscopy study
40. Noninvasive evaluation of mineral content of bone without use of ionizing radiation
41. 31P-MR spectroscopy study